Virax Biolabs VRAX Balance Sheet (2021-2026)

NASDAQ VRAX
$3.21 -0.24 (-6.96%)
As of: Aug 21, 2026 · 2:38 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2021 Mar2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 0.02M0.02M9.35M3.59M7.29M4.23M6.44M
Cash & Current Investments (Quarter) 0.02M0.02M9.35M3.59M7.29M4.23M6.44M
Short-term Investments (Quarter) 0.07M0.12M
Receivables - Net (Quarter) 928.00
Receivables (Quarter) 928.00
Raw Materials (Quarter) 0.05M
Work In Process (Quarter) 0.03M
Finished Goods (Quarter) 0.06M0.05M
Inventory (Quarter) 0.02M0.02M0.06M0.13M0.09M
Prepaid Assets (Quarter) 0.54M0.36M
Current Assets (Quarter) 0.04M0.05M9.63M4.38M4.89M6.83M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) -0.01M-0.00M1.23M1.17M
Intangibles (Quarter) 0.18M
Goodwill & Intangibles (Quarter) 0.18M
Non-Current Assets (Quarter) 0.18M1.10M1.53M1.50M
Assets (Quarter) 0.04M0.05M9.81M5.48M9.44M6.43M8.32M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.22M1.12M0.16M0.12M0.42M0.25M0.31M
Notes Payables (Quarter) 0.34M0.27M
Payables (Quarter) 0.22M1.12M0.16M0.12M0.42M0.59M0.58M
Short term Debt (Quarter) 0.15M0.03M0.03M
Current Leases (Quarter) 0.05M0.05M0.08M
Current Deferred Revenue (Quarter) 0.04M
Total Current Liabilities (Quarter) 0.87M1.25M0.91M0.17M0.67M0.69M
Non-Current Liabilities
Minority Interest (Quarter) -0.23M-0.24M
Operating Leases (Quarter) 0.22M0.29M0.30M
Total Liabilities (Quarter) 0.87M1.25M0.91M0.35M9.44M0.96M0.99M
Shareholder's Equity
Total Debt (Quarter) 0.15M0.03M0.03M
Common Equity (Quarter) -0.83M-1.20M8.90M5.14M5.70M7.33M
Liabilities and Shareholders Equity (Quarter) 0.04M0.05M9.81M5.48M9.44M6.43M8.32M
Retained Earnings (Quarter) -0.00M-6.34M-11.79M-18.53M-24.59M-29.61M